Form 4: Linde PLC Executive Pfann Oliver Reports Stock and Option Awards
SEC Form 4
Senior Vice President of EMEA at Linde PLC, Oliver Pfann, reports the acquisition of restricted stock units and stock options.
Summary
- Oliver Pfann, Senior Vice President, EMEA of Linde PLC, filed a Form 4 detailing changes in beneficial ownership.
- The filing reports the acquisition of 905 Restricted Stock Units (RSUs) that will vest on or about March 7, 2027.
- Pfann also acquired 5,840 stock options with an exercise price of $465.29, vesting in equal annual installments beginning March 7, 2025, and expiring on March 7, 2034.
- The filing also details existing holdings of RSUs and stock options with varying exercise prices and vesting schedules.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it's a standard regulatory filing detailing stock and option awards to an executive. It doesn't inherently indicate positive or negative performance.
Positives
- The acquisition of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedules of the options and RSUs incentivize long-term performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The granting of stock options and RSUs can motivate the executive to improve company performance, potentially benefiting shareholders.
- The dilution effect of new shares issued upon vesting of RSUs and exercise of options is minimal.
Key Dates
| Date | Description |
|---|---|
| 03/09/2021 | Start date for vesting of 3,590 stock options with an exercise price of $173.13. |
| 03/08/2022 | Start date for vesting of 3,055 stock options with an exercise price of $253.68. |
| 03/07/2023 | Start date for vesting of 1,860 stock options with an exercise price of $270.99. |
| 03/07/2024 | Date of transaction for the acquisition of stock options and restricted stock units. |
| 03/07/2024 | Start date for vesting of 1,500 stock options with an exercise price of $354.14. |
| 03/08/2024 | Payout date for 290 Restricted Stock Units. |
| 03/07/2025 | Start date for vesting of 5,840 stock options with an exercise price of $465.29. |
| 03/07/2025 | Payout date for 215 Restricted Stock Units. |
| 03/07/2026 | Payout date for 230 Restricted Stock Units. |
| 03/07/2027 | Payout date for 905 Restricted Stock Units. |
| 03/07/2030 | Expiration date for 3,590 stock options with an exercise price of $173.13. |
| 03/08/2031 | Expiration date for 3,055 stock options with an exercise price of $253.68. |
| 03/07/2032 | Expiration date for 1,860 stock options with an exercise price of $270.99. |
| 03/07/2033 | Expiration date for 1,500 stock options with an exercise price of $354.14. |
| 03/07/2034 | Expiration date for 5,840 stock options with an exercise price of $465.29. |
| 03/11/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.